NCT01350024

Brief Summary

Conjunctival Mullerectomy is a well known procedure used to correct upper lid ptosis via a posterior approach. Patients who undergo this procedure are often given local anesthesia to alleviate intraoperative and postoperative pain. Local anesthesia can be given via frontal nerve block or subconjunctival injection combined with sedation in most cases. Both techniques are currently acceptable options for local anesthesia, however postoperative pain has not been systematically evaluated between these two techniques. The investigators aim to compare intra-operative and postoperative pain with these two techniques in patients undergoing conjunctival Mullerectomy for ptosis repair. Patients will be randomized to receive local anesthesia via frontal nerve block or via subconjunctival injection. In addition, the investigators will measure the surgical outcomes of the ptosis surgery with standard measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 9, 2011

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2016

Completed
Last Updated

May 30, 2017

Status Verified

May 1, 2017

Enrollment Period

5.3 years

First QC Date

May 5, 2011

Last Update Submit

May 24, 2017

Conditions

Keywords

Conjunctival MullerectomyBlepharoptosisPtosis surgeryPain Control

Outcome Measures

Primary Outcomes (1)

  • Pain control

    Patients will be asked to complete a survey regardning pain assessment twenty-four hours after completion of surgery.

    24 hour after surgery

Secondary Outcomes (2)

  • Efficacy of ptosis surgery

    2 months

  • Pain Control

    1 hour after surgery

Study Arms (2)

Frontal Nerve Block

ACTIVE COMPARATOR

Patients will receive a frontal nerve block for anesthesia

Procedure: Frontal nerve block with 2% lidocaine with 1:100,000 dilution of epinephrine

Subconjucntival Injection

ACTIVE COMPARATOR

Patients will receive a subconjunctival injection for anesthesia

Procedure: Subconjunctival injection of 2% lidocaine with 1:100,000 dilution with epinephrine

Interventions

Frontal Nerve Block 5 cc will be administered preoperatively once.

Frontal Nerve Block

Patients will receive a 1.5 cc dose of subconjunctival lidocaine as above

Subconjucntival Injection

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and older
  • Patient with ptosis that requires correction
  • Patient is able to consent for themselves

You may not qualify if:

  • Patient unable to complete survey
  • Patient had prior lid surgery
  • Patient taking chronic pain medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bascom Palmer Eye Institute

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

BlepharoptosisAgnosia

Interventions

LidocaineIndicator Dilution TechniquesEpinephrine

Condition Hierarchy (Ancestors)

Eyelid DiseasesEye DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesInvestigative TechniquesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Professor of Clinical

Study Record Dates

First Submitted

May 5, 2011

First Posted

May 9, 2011

Study Start

May 1, 2011

Primary Completion

July 30, 2016

Study Completion

July 30, 2016

Last Updated

May 30, 2017

Record last verified: 2017-05

Locations